Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOZANTINIB S-MALATE Cause Tooth disorder? 318 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 318 reports of Tooth disorder have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.8% of all adverse event reports for CABOZANTINIB S-MALATE.

318
Reports of Tooth disorder with CABOZANTINIB S-MALATE
0.8%
of all CABOZANTINIB S-MALATE reports
4
Deaths
25
Hospitalizations

How Dangerous Is Tooth disorder From CABOZANTINIB S-MALATE?

Of the 318 reports, 4 (1.3%) resulted in death, 25 (7.9%) required hospitalization.

Is Tooth disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 318 reports have been filed with the FAERS database.

What Other Side Effects Does CABOZANTINIB S-MALATE Cause?

Diarrhoea (8,282) Fatigue (6,819) Off label use (5,245) Nausea (4,341) Decreased appetite (4,076) Blood pressure increased (2,939) Malignant neoplasm progression (2,718) Palmar-plantar erythrodysaesthesia syndrome (2,706) Weight decreased (2,657) Stomatitis (2,560)

What Other Drugs Cause Tooth disorder?

DENOSUMAB (2,553) LENALIDOMIDE (1,766) ETANERCEPT (820) APIXABAN (727) ADALIMUMAB (648) RITUXIMAB (512) ABATACEPT (511) TOCILIZUMAB (488) METHOTREXATE (446) POMALIDOMIDE (328)

Which CABOZANTINIB S-MALATE Alternatives Have Lower Tooth disorder Risk?

CABOZANTINIB S-MALATE vs CAFFEINE CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL CABOZANTINIB S-MALATE vs CALCIFEDIOL CABOZANTINIB S-MALATE vs CALCIPOTRIENE

Related Pages

CABOZANTINIB S-MALATE Full Profile All Tooth disorder Reports All Drugs Causing Tooth disorder CABOZANTINIB S-MALATE Demographics